Psychotropics and Related Topics From
Sixteen Years of Peer-Review Articles

NOTE FOR READERS: While most pharmacologic agents are called out by name, some articles may be overviews of entire classes of agents. For example, under sections such as ANTIDEPRESSANTS (not specified), the reader would find the following article: Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients.

Likewise, certain pharmacologic advances can be rationalized only in the context of the disease itself. Among drug categories, you will find ‘non specified’ sections on Epidemiology, Bipolar, and Sleep Disturbances, to name just a few. Rather than omit entire categories of research because they did not correspond to a strict listing of drug names, we chose to deviate in certain instances for the sake of completeness. We hope this does not contribute to any confusion.

All articles prefaced with the    logo are indexed on PubMed.com under Psychopharmacol Bull.
— Sincerely, The Editors

VIEW UPDATED 2018 PSYCHOTROPIC DOSAGE RANGES

DISCLAIMER: Although every effort has been made to ensure that drug information is presented accurately in all Medworks’ publications, the ultimate responsibility rests with the prescribing physician. Neither the publisher, nor the authors can be held responsible for errors or for any consequences arising from the use of information contained herein. Readers are strongly urged to consult additional relevant primary literature. No claims or endorsements are made for any drug or compound currently under clinical investigation.

ADHD (Not Specified)

 – Persisting Psychosocial Impairments in Adults Being Treated with Medication for Attention Deficit/Hyperactivity Disorder

 – Unmet Medication Coverage Needs among Adults with Attention Deficit/Hyperactivity Disorder (ADHD)

Agomelatine

 – Agomelatine for Depression in Schizophrenia: A Case-Series

Alprazolam

 – The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder

Alzheimer’s

 – Progressive Non-familial Adult onset Cerebellar Degeneration: An Unusual Occurrence with Hashimoto’s Thyroiditis

Alternative Medicine

 – Determinants of Complementary and Alternative Medicine Use by Patients with Bipolar Disorder 

Ambulatory Pschiatry (Not Specified)

 – Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist

Amisulpride

 – Amisulpride for Clozapine Induced Sialorrhea

Amitriptyline

 – Citalopram Versus Amitriptyline in Elderly Depressed Patients with or without Mild Cognitive Dysfunction: A Danish Multicentre Trial in General Practice

Anticonvulsants (not specified)

 – Evidence-Based Mental Health Use of Anticonvulsants During Pregnancy

 – Pharmacokinetics of Mood Stabilizers and New Anticonvulsants 

Innovative Treatment Strategies With Anticonvulsants: A Focus On Bipolar Disorder 

Antidepressants (not specified)

 – Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients

 – Comparing The Methods Used To Compare Antidepressants 

 – A Survey of Prescribing Preferences in the Treatment of Refractory Depression: Recent Trends 

Great Expectations In Stereochemistry: Focus On Antidepressants 

A Discussion On The Methodologies Used To Evaluate Antidepressants 

 –Impact Of A Student Pharmacist Driven Medication Reconciliation And Antidepressant Treatment History Project At A Depression Clinic: A Pilot Study

Antipsychotics (not specified)

 – Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis

 – Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?

 – Lack of Efficacy of Antipsychotics on Premenstrual Psychosis: A Case Report

 – Antipsychotic Induced Symptomatic Hyperprolactinemia: Are Dopamine Agonists Safe? 

 – Metabolic Syndrome with Different Antipsychotics: A Multicentre Cross-Sectional Study 

 – The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication 

 – Antipsychotic Medications and Sudden Cardiac Death 

 – Antipsychotic-Induced Hyperprolactinemia and Sexual Dysfunction 

 – Sexual Side Effects Associated With Conventional and Atypical Antipsychotics 

 – Therapeutic Drug Monitoring of Antipsychotics 

 –Combined Antipsychotics And Electroconvulsive Therapy In An Acutely Psychotic Patient With Treatment-Resistant Schizophrenia

 –Sex Differences In Antipsychotic Related Metabolic Functioning In Schizophrenia Spectrum Disorders

Arpiprazole Lauroxil

 – A Phase-1 Study Comparing Pharmacokinetic And Safety Profiles Of Three Different Dose Intervals Of Aripiprazole Lauroxil

 – Metabolic And Endocrine Profiles During 1-Year Treatment Of Outpatients With Schizophrenia With Aripiprazole Lauroxil

Atomoxetine

 – Atomoxetine Induced Hypothermia: A Case Report 

Aripiprazole

 – Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010) 

 – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD 

 – Efficacy of High-Dose Aripiprazole for Treatment-Resistant Schizoaffective Disorder: A Case Report

 – Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial 

 -Aripiprazole-Induced Asymptomatic Hypertension: A Case Report

Asenapine

 – An Open Label Pilot Study Of Adjunctive Asenapine For The Treatment Of Posttraumatic Stress Disorder

 – Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale